Previous analyses have reported that mutations in genes beta 2 microglobulin (B2M) and transforming growth factor receptor 2 (TGFBR2) may contribute to impaired immune surveillance in HNSCC [52]. The gene discussed is B2M; the disease is head and neck squamous cell carcinoma.